返回 Agendas
TransCelerate Collaboration: Harmonization Efforts to Find Solutions to Critical Industry Challenges
Session Chair(s)
Andy Lee, MA
Senior Vice President, Head of Global Clinical Trial Operations
Merck & Co., Inc., United States
Collaboration among TransCelerate Biopharma Inc. (TransCelerate) member companies is driving industry innovation. In this session, we will examine how these 21 participating member companies are driving innovation to address clinical trial execution pain points through their 12 chartered work streams. We will also address the mission of TransCelerate, what solutions have been delivered so far, and what to expect in 2015 and beyond.
Learning Objective : Identify key accomplishments of risk-based monitoring, data standards, site qualification and training initiatives; Provide highlights of upcoming innovation through a shared investigator platform, placebo/standard of care data sharing initiative, and a common protocol template; Describe the value these initiatives will have on simplifying clinical trials across the industry.
Speaker(s)
Panelist
Jackie Kent
Society for Clinical Research Sites (SCRS), United States
Vice President, Diversity and Special Projects
Panelist
Brett Wilson
Pfizer Inc, Canada
Senior Director, Global Biometrics and Data Management
Panelist
Edward Bowen
Transcelerate Biopharma, United States
Lead, Placebo as Standard of Care Workstream
Panelist
Robert DiCicco, PharmD
TransCelerate Biopharma Inc., United States
Vice President, Portfolio Management